🇺🇸 FDA

Drug profile · INN

ulipristal acetate

ELLAONE

approved G03AD02
US status
approved
Patents linked
8
News articles
0

Quick answer

ulipristal acetate (ELLAONE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN ulipristal acetate
Brand ELLAONE
Route ORAL
Formulation TABLET
ATC code G03AD02
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 12419942

    Use of the Salmonella spp type III secretion proteins as a protective vaccination

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12390512

    Depolymerase capable of degrading extracellular polymeric substances of Klebsiella pneumoniae

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12203143

    Methods and kits to identify Klebsiella strains

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12071636

    Pasteurella multocida strains and vaccines having hyaC and nanP deletions

    Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11717542

    Using tumor-navigating Salmonella to modulate tumor metabolism

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11529312

    Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use

    Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11519007

    Tumor-navigating, self-eradicating, trail-armed salmonella for precision cancer therapy

    Expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11464843

    Use of the salmonella SPP type III secretion proteins as a protective vaccination

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is ulipristal acetate?

ulipristal acetate (ELLAONE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for ulipristal acetate?

ELLAONE is a marketed brand name for ulipristal acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ulipristal acetate?

ulipristal acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.